Atlas Trials

Vaccine Therapy in Preventing Cancer Recurrence in Patients With Non-Metastatic, Node Positive, HER2 Negative Breast Cancer That is in Remission

Clinical trial NCT02780401 · COMPLETED

Trial details

NCT number
NCT02780401
Sponsor
University of Washington
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
HER2/Neu NegativeNo Evidence of DiseaseOne or More Positive Axillary NodesStage IB Breast CancerStage II Breast CancerStage IIA Breast CancerStage IIB Breast CancerStage III Breast CancerStage IIIA Breast CancerStage IIIB Breast CancerStage IIIC Breast Cancer
Start date
2016-09-02
Primary completion
2020-10-08
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.